Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Person holding their wrist in pain

Carpal tunnel syndrome (CTS) and trigger finger (TF) are the two most common diseases of the hand, accounting for over 60,000 operations per year in the UK alone, and large economic cost worldwide.

It is well known among hand surgeons that these two conditions often occur together, but the reason for this is unknown.

Dr Akira Wiberg, NIHR Clinical Lecturer in Plastic Surgery and co-senior author of the study said: “We’ve known for a long time that trigger finger and carpal tunnel syndrome – two of the commonest hand diseases worldwide – frequently co-exist in patients, but the reason for this has remained unclear. We’ve shown for the first time that this co-occurrence can partly be explained by genetics.”

The Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) researchers hypothesised that the co-occurrence of carpal tunnel syndrome and trigger finger may in part be explained by a shared genetic predisposition.  To test the theory, they performed a genome-wide association study (GWAS) of trigger finger in the UK Biobank, a population-based cohort of approx. half a million participants from the UK, and discovered five regions in the genome where sufferers of trigger finger carry, on average, different genetic variants from people who don’t have trigger finger.

One of those genetic variants is the same variant that increases the risk of carpal tunnel syndrome, which the team previously discovered in their 2019 GWAS of carpal tunnel syndrome. The genetic variant allows for increased signalling through a growth hormone known as “Insulin-like Growth Factor 1”, or IGF-1 pathway.

Read the full story on the NDORMS website

Similar stories

EAVI2020: The Quest for an HIV Vaccine

In this long read published to coincide with International AIDS Day, we explore how an international collaboration – of which the University of Oxford is a key partner – has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.

New SMRU building opened in Thailand to provide health care to marginalized populations

The inauguration of a new joint Shoklo Malaria Research Unit (SMRU) and Borderland Health Foundation (BHF) Building took place in Mae Ramat, Thailand, this week.

Smoking increases the risks of 56 diseases in Chinese adults

Smoking increases the risks of 56 diseases and kills more than one million adults in China each year from 22 different causes, according to new research published in The Lancet Public Health.

Success for Oxford researchers in The Genetics Society 2023 Awards

Researchers from Department of Physiology, Anatomy and Genetics, Radcliffe Department of Medicine and Nuffield Department of Population Health have been recgonised in The Genetics Society 2023 awards.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.